Telesis bio stock.

Feb 21, 2023 · The Last 12 Months Of Insider Transactions At Telesis Bio. Over the last year, we can see that the biggest insider purchase was by President Todd Nelson for US$192k worth of shares, at about US$1. ... SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their ...Discover historical prices for TBIO stock on Yahoo Finance. View daily, weekly or monthly format back to when Telesis Bio, Inc. stock was issued. TBIO (U.S.: Nasdaq) Overview News Telesis Bio Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-1.31 Market Cap $11.99 M 29.98 M Public Float...

Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of ...Nov 20, 2023 · The average price predicted for Telesis Bio Inc (TBIO) by analysts is $4.00, which is $3.63 above the current market price. The public float for TBIO is 8.76M, and at present, short sellers hold a 3.69% of that float. On November 20, 2023, the average trading volume of TBIO was 38.46K shares.

Convertible preferred stock - ... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the …

SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, and Cellibre, a leading manufacturing technology company, today announced initiation of work under a collaboration to optimize the development and validation of Telesis Bio’s BioXp ® Digital …SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced its speaker lineup for presentations at SynBioBeta’s Built with Biology Global Conference, which is being held in Oakland, Calif., on April 12-14, 2022. Codex DNA will be showcasing its …Translate Bio, Inc. (NASDAQ:TBIO) announced its quarterly earnings results on Wednesday, August, 4th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.44. The business earned $72.65 million during the quarter, compared to the consensus estimate of $38.23 million.Telesis Bio reflects that expansion and growth,” stated Dr. Nelson. The new name reflects the focus, strategic vision, and growth of the Company. There will be no change to corporate structure ...This month, we saw the Telesis Bio, Inc. (NASDAQ:TBIO) up an impressive 40%.But that hardly compensates for the shocking decline over the last twelve months. Specifically, the stock price nose ...

Translate Bio, Inc. (NASDAQ:TBIO) announced its quarterly earnings results on Wednesday, August, 4th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.44. The business earned $72.65 million during the quarter, compared to the consensus estimate of $38.23 million.

Apr 17, 2023 · Telesis Bio and PagerDuty Surge Following Zacks Rank Upgrade Shares of Telesis Bio, Inc. ( TBIO Quick Quote TBIO - Free Report ) have soared 77.9% since it was upgraded to a Zacks Rank #2 (Buy) on ...

Managing stock as per market demand, generate demand of products, maintain ... Tabisam Khan. Senior Director @ Telesis Bio | Synthetic Biology, Drug Development.Jan 11, 2023 · This month, we saw the Telesis Bio, Inc. (NASDAQ:TBIO) up an impressive 40%.But that hardly compensates for the shocking decline over the last twelve months. Specifically, the stock price nose ... 4 days ago ... Title of each class. Trading Symbol(s). Name of each exchange on which registered ; Common Stock, $0.0001 par value per share. TBIO. Nasdaq ...Get Telesis Bio Inc (TBIO.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsSAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, and Cellibre, a leading manufacturing technology company, today announced initiation of work under a collaboration to optimize the development and validation of Telesis Bio’s BioXp ® Digital …Telesis Bio, Inc. Equities TBIO US1920031010 Advanced Medical Equipment & Technology Market Closed - Nasdaq ... Stock Telesis Bio, Inc. - Nasdaq . News Telesis Bio, Inc. CODEX DNA, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of …Stock Performance. Shares of Telesis Bio were trading at $0.681 as of November 09. Over the last 52-week period, shares are down 61.71%. Given that these returns are generally negative, long-term ...

Nov 13, 2023 · Gibson Daniel Glenn, the Chief Technology Officer of Telesis Bio Inc, sale 1,190 shares at $2.83 during a trade that took place back on May 04, which means that Gibson Daniel Glenn is holding 102,083 shares at $3,363 based on the most recent closing price. Stock Fundamentals for TBIO. Current profitability levels for the company are sitting at: SAN DIEGO, May 10, 2022 -- Codex DNA, Inc. , a pioneer in automated benchtop synthetic biology systems, today reported financial results for the first quarter ended March 31, 2022. “In the... | June 17, 2023TBIO Telesis Bio Inc Form 8-K - Current report. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).Stock Trading Strategies All; America; Europe; Asia; Our Shows Shows Strategy Must Watch Satirical Cartoon Today's Editorial Crypto Recap Stock Picks All our investments ... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks …Telesis Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 Nov. 13: CI Telesis Bio, Inc. Provides Earnings Guidance for 2023 Nov. 13: CI Telesis Bio, Inc. Announces Default of 2022 Term Loan Agreement Nov. 09Telesis Bio Inc (TBIO) Stock Price & News - Google Finance Markets Dow Jones 34,337.87 +0.16% +54.77 S&P 500 4,411.55 -0.084% -3.69 13,767.74 -0.22% -30.36 Russell 1,705.50 +0.010% +0.18 VIX...

Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of ...Telesis Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 Nov. 13: CI Telesis Bio, Inc. Provides Earnings Guidance for 2023 Nov. 13: CI Telesis Bio, Inc. Announces Default of 2022 Term Loan Agreement Nov. 09

Nov 18, 2023 · Telesis Bio Inc (NASDAQ:TBIO) showed a performance of -61.05% in past 30-days. Number of shares sold short was 0.32 million shares which calculate 14.15 days to cover the short interests. Wall Street analysts have assigned a consensus price target of $4.00 to the stock, which implies a rise of 90.75% to its current value. Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of ...Median, 31.086 M ; Mean, 665 M ; Standard Deviation, 2.375 B ; Company. AboutPricing PlansPrivacy PolicyTerms Of UseSupport ; Product. Stock ScreenerStock Ideas ...Feb 21, 2023 · The Last 12 Months Of Insider Transactions At Telesis Bio. Over the last year, we can see that the biggest insider purchase was by President Todd Nelson for US$192k worth of shares, at about US$1. ... SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their ...Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of ...SAN DIEGO, Nov. 13, 2023 -- Telesis Bio Inc. , a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter of 2023. “This quarter, we...Convert Telesis Bio Inc. stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock. apple; wise; Select a currency. USD. …Jan 11, 2023 · This month, we saw the Telesis Bio, Inc. (NASDAQ:TBIO) up an impressive 40%.But that hardly compensates for the shocking decline over the last twelve months. Specifically, the stock price nose ... Stock Trading Strategies All; America; Europe; Asia; Our Shows Shows Strategy Must Watch Satirical Cartoon Today's Editorial Crypto Recap Stock Picks All our investments ... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks …

This could make Telesis Bio Inc less attractive for value investors when compared to the industry median at 1.99. You can read more about Telesis Bio Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.

Stock Quote + Chart | Telesis Bio Stock Quote + Chart Stock Quote + Chart | Historic Price Lookup | Analyst Coverage Stock quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock chart FL Technical Analysis Tools & Settings Open High Low Close Volume Volume remove 1DY | 5DY | 1M | 3M | 6M | YTD | 1Y |

Stock Trading Strategies All; America; Europe; Asia; Our Shows Shows Strategy Must Watch Satirical Cartoon Today's Editorial Crypto Recap Behind the numbers Stock Picks ... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks …SAN DIEGO, May 10, 2022 -- Codex DNA, Inc. , a pioneer in automated benchtop synthetic biology systems, today reported financial results for the first quarter ended March 31, 2022. “In the... | June 17, 2023About Telesis Bio Telesis Bio Inc. is building biology. Creators of the BioXp® system, the world’s only fully automated gene synthesis platform, and the industry-standard Gibson Assembly® method, Telesis Bio Inc. is focused on enabling researchers with the tools they need to rapidly and securely design, code, and create synthetic DNA.SAN DIEGO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, ...Taking into account the latest results, the most recent consensus for Telesis Bio from three analysts is for revenues of US$42.2m in 2023 which, if met, would be a substantial 101% increase on its ...Legal Name Telesis Bio Inc. Stock Symbol NASDAQ:TBIO. Company Type For Profit. Contact Email [email protected]. Phone Number +1 855-474-4362. Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA. Telesis Bio was founded in 2013 and was headquartered in San Diego, USA.Telesis Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 Nov. 13: CI Telesis Bio, Inc. Provides Earnings Guidance for 2023 Nov. 13: CI Telesis Bio, Inc. Announces Default of 2022 Term Loan Agreement Nov. 09TELESIS BIO INC's stock had its IPO on June 18, 2021, making it an older stock than just 6.05% of US equities in our set. With a year-over-year growth in debt of 193.23%, TELESIS BIO INC's debt growth rate surpasses 94.24% of about US stocks. As for revenue growth, note that TBIO's revenue has grown 81.36% over the past 12 months; that beats the …May 31, 2023 · Telesis Bio (NASDAQ:TBIO) said Wednesday it has signed an agreement with institutional investors to provide the company with funding of $28 million through a private placement of redeemable ... 13 Nov 2023 ... (TBIO) on Monday reported a loss of $10.6 million in its third quarter. On a per-share basis, the San Diego-based company said it had a loss of ...Nov 18, 2023 · Telesis Bio Inc (NASDAQ:TBIO) showed a performance of -61.05% in past 30-days. Number of shares sold short was 0.32 million shares which calculate 14.15 days to cover the short interests. Wall Street analysts have assigned a consensus price target of $4.00 to the stock, which implies a rise of 90.75% to its current value. Telesis Bio. SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its ...

SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2023 financial results on Monday, November 13, 2023, after the market closes. The press release can be accessed via the Investor section of Telesis Bio ...SAN DIEGO, Calif., June 14, 2021 (GLOBE NEWSWIRE) — Telesis Bio, Inc. (“Telesis Bio”), creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today announced the launch of its public offering of 6.7 million shares of its common stock. The initial public offering price is ...Telesis Bio, Inc. (TBIO) is a leader in automated multi-omic and synthetic biology solutions. The stock price, news, quote and history of the company are available on Yahoo Finance. See the latest performance outlook, earnings date, dividend yield, analyst report and more. Telesis Bio is home to Gibson Assembly, and pioneering synthetic DNA/gene synthesis hardware, including the BioXp, the world’s first DNA printer. Our mission is to empower scientific researchers in both academic and commercial settings with the materials and methods to rapidly and accurately write large quantities of synthetic genes.Instagram:https://instagram. how to make money with currency exchangecatapiller stockq.ai forbesnasdaq lpcn View the latest Telesis Bio Inc. (TBIO) stock price, news, historical charts, analyst ratings and financial information from WSJ. can you buy a house with 600 credit scoreishares silver trust stock price Telesis Bio (NASDAQ:TBIO) said Wednesday it has signed an agreement with institutional investors to provide the company with funding of $28 million through a private placement of redeemable ...Nov 13, 2023 · SAN DIEGO, Nov. 13, 2023 -- Telesis Bio Inc. , a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter of 2023. “This quarter, we... portfolio management platform Nov 22, 2023 · forbes.com - April 12 at 11:56 PM. Telesis Bio Shares Rise 10% After Release of Two New DNA Kits. marketwatch.com - March 31 at 4:50 PM. Telesis Bio Shares Climb 35% on 2023 Revenue Guidance. marketwatch.com - March 22 at 1:19 PM. Telesis Bio: Q4 Earnings Snapshot. sfgate.com - March 21 at 4:52 PM. The average price recommended by analysts for Telesis Bio Inc (TBIO) is $4.00, which is $3.66 above the current market price. The public float for TBIO is 8.76M and currently, short sellers hold a 3.69% of that float. On November 28, 2023, TBIO’s average trading volume was 182.53K shares. The electric vehicle boom is accelerating – and fast.